本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lexeo Therapeutics

4.25
-0.1100-2.52%
盤後4.250.00000.00%19:30 EDT
成交量:149.08萬
成交額:638.04萬
市值:3.49億
市盈率:-3.71
高:4.48
開:4.43
低:4.21
收:4.36
52周最高:10.99
52周最低:3.99
股本:8,204.63萬
流通股本:5,122.95萬
量比:4.38
換手率:2.91%
股息:- -
股息率:- -
每股收益(TTM):-1.1457
每股收益(LYR):-1.8634
淨資產收益率:-46.76%
總資產收益率:-27.59%
市淨率:1.48
市盈率(LYR):-2.28

資料載入中...

2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/30

重要事件披露

Form 8-K - Current report
2026/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/27

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/26

SEC問詢函

Form CORRESP - Correspondence
2025/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities